Author

Barry J. Kappel

Sapience TherapeuticsORCID 0000-0002-0344-8826Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Abi Vainstein‐Haras· 1 shared B.H. Lee· 1 shared Claudio ScuoppoiD· 1 shared Erin GallagheriD· 1 shared Franco Abbate· 1 shared Gene MerutkaiD· 1 shared Jimmy A. RotoloiD· 1 shared Julia Diehl· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abi Vainstein‐Haras

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 21, 2026

Synergistic anti-tumor activity of EGFR inhibition and C/EBPβ antagonism in GBM.

Julia Diehl, Claudio Scuoppo, Rick Ramirez…·Jimmy A. Rotolo

This study shows that combining EGFR inhibition with C/EBPβ antagonism enhances anti-tumor activity in GBM, based on in vitro and in vivo experiments and clinical data.

DOI 10.64898/2026.04.17.719281

humanbulk RNA-seq

𝕏 PostBluesky